DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Bryostatin 1 is an investigational drug.
There have been 40 clinical trials for Bryostatin 1. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 1997.
The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are National Cancer Institute (NCI), Barbara Ann Karmanos Cancer Institute, and Virginia Commonwealth University.
Recent Clinical Trials for Bryostatin 1
|A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease||Neurotrope Bioscience, Inc.||Phase 2|
|Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment||Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||Phase 1|
|Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease||Blanchette Rockefeller Neurosciences Insitute||Phase 1/Phase 2|